Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Suramin is a polysulfonated naphthylurea that inhibits the function of growth factors and growth factor receptors implicated in glioma progression, angiogenesis, and radioresistance. The safety and benefits of combining inhibitors of angiogenesis and growth factors with cytotoxic therapies in patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Laterra, John J., Grossman, Stuart A., Carson, Kathryn A., Lesser, Glenn J., Hochberg, Fred H., Gilbert, Mark R.
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2004
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871972/
https://ncbi.nlm.nih.gov/pubmed/14769135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados